Transcriptional and epigenetic rewiring by the NUP98::KDM5A fusion oncoprotein directly activates CDK12
Selina Troester(Institute for Research in Biomedicine), Florian Grebien(University of Veterinary Medicine Vienna), Johannes Schmoellerl(Research Institute of Molecular Pathology), Martin Piontek(University of Veterinary Medicine Vienna), Thomas Eder, Pablo Fernández‐Pernas(University of Veterinary Medicine Vienna), Kaan Boztuǧ(Forschungszentrum Jülich), Margarita Maurer‐Granofszky(St Anna Children's Hospital), Roland Meisel(Düsseldorf University Hospital), Karin Nebral(St Anna Children's Hospital), Ben Haladik(Austrian Academy of Sciences), Michael Dworzak(St. Anna Children's Cancer Research Institute), Nastassja K. Scheidegger(University of Zurich), Giulio Superti‐Furga(Austrian Academy of Sciences), Gabriele Manhart(University of Veterinary Medicine Vienna), Johannes Zuber(Research Institute of Molecular Pathology), Melanie Allram(University of Veterinary Medicine Vienna), Peter Valent(Medical University of Vienna), Nadja Wukowits(University of Veterinary Medicine Vienna), Beat Bornhäuser(University Children's Hospital Zurich)
Cited by 8
Related Papers
Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase–mediated tryptophan degradation
|Blood|2004|1.6k
Diagnostic criteria and classification of mastocytosis: a consensus proposal
|Leukemia Research|2001|1.1k
Toward understanding and exploiting tumor heterogeneity
|Nature Medicine|2015|770
Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statement
|European Heart Journal|2021|589